Species: Neisseria sicca (HMT-0764) Primary Body Site: Oral
Download Options
Hide Legend
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Body Site Legend:
| SUBP-- Subgingival Plaque |
| SUPP -- Supragingival Plaque |
| PERIO -- Periodontal |
| AKE -- Attached Keratinized Gingiva |
| BMU -- Buccal Mucosa |
| HPA -- Hard Palate |
| SAL -- Saliva |
| THR -- Throat |
| PTO -- Palatine Tonsils |
| TDO -- Tongue Dorsum |
| ANA -- Anterior Nares |
| LRC -- L_Retroauricular Crease |
| RRC -- R_Retroauricular Crease |
| LAF -- L_Antecubital Fossa |
| RAF -- R_Antecubital Fossa |
| VIN -- Vaginal Introitus |
| MVA -- Mid Vagina |
| PFO -- Posterior Fornix |
| STO -- Stool |
Prev - Prevalence
10thp - 10th percentile
90thp - 90th percentile
ND - less than 0.001%
Human Microbiome Project Mapping (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 0.78 | 1.01 | 0.11 | 0.17 | 0.44 | 0.10 | 0.40 | 0.07 | 0.08 | 0.07 | 0.02 | 0.03 | 0.04 | 0.36 | 0 | 0.03 | 0.01 | 0 |
| n | 24 | 395 | 24 | 15 | 323 | 1 | 8 | 7 | 22 | 423 | 65 | 23 | 30 | 1 | 4 | 8 | 94 | 375 |
| 10thp | 0.03 | 0.04 | 0 | 0 | 0.01 | 0.10 | 0.10 | 0 | 0 | 0.01 | 0 | 0 | 0 | 0.36 | 0 | 0 | 0 | 0 |
| 90thp | 1.87 | 2.50 | 0.20 | 0.51 | 1.18 | 0.10 | 0.72 | 0.14 | 0.20 | 0.17 | 0.07 | 0.05 | 0.02 | 0.36 | 0 | 0.07 | 0.01 | 0 |
| Stdev | 0.87 | 1.61 | 0.36 | 0.32 | 0.79 | 0 | 0.30 | 0.07 | 0.12 | 0.09 | 0.04 | 0.08 | 0.17 | 0 | 0 | 0.08 | 0.07 | 0.07 |
| Prev(%) | 66.67 | 82.78 | 8.33 | 26.67 | 44.89 | 100.00 | 50.00 | 14.29 | 4.55 | 25.53 | 1.54 | 0 | 3.33 | 0 | 0 | 12.50 | 1.06 | 0.27 |
Eren V1-V3 www.pnas.org
(Data from healthy subjects.)
Notes:
reads equally close to N. flava, N. macacae, N. mucosa, and N. sicca were assigned one fourth to each taxon
reads equally close to N. flava, N. macacae, N. mucosa, and N. sicca were assigned one fourth to each taxon
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.61 | 0.79 | 0.12 | 0.29 | 0.14 | 0.20 | 0.04 | 0.03 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.70 | 2.06 | 0.20 | 0.78 | 0.22 | 0.35 | 0.11 | 0.05 | 0.03 | 0 |
| Stdev | 1.21 | 1.31 | 0.36 | 0.79 | 0.51 | 0.42 | 0.11 | 0.12 | 0.02 | 0 |
| Prev(%) | 80.52 | 83.12 | 54.55 | 79.22 | 72.73 | 72.73 | 48.05 | 46.75 | 40.26 | 3.90 |
Eren V3-V5 www.pnas.org
(Data from healthy subjects.)
Notes:
Reads equally close to N. flava, N. macacae, N. mucosa, and N. sicca were assigned one-fourth to each taxon.
Reads equally close to N. flava, N. macacae, N. mucosa, and N. sicca were assigned one-fourth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | STO | |
| Avg (%) | 0.63 | 1.08 | 0.12 | 0.38 | 0.20 | 0.42 | 0.07 | 0.09 | 0.03 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 1.38 | 3.06 | 0.19 | 1.15 | 0.40 | 1.06 | 0.19 | 0.12 | 0.07 | 0 |
| Stdev | 1.15 | 1.51 | 0.33 | 0.79 | 0.56 | 0.58 | 0.14 | 0.31 | 0.05 | 0 |
| Prev(%) | 85.81 | 93.24 | 57.43 | 86.49 | 81.76 | 87.16 | 65.54 | 66.89 | 58.78 | 0 |
Human Microbiome Project 16S RefSeq (V1-V3) (Data from healthy subjects. - not published)
Notes:
Because HMT-682 is not present individually, all equidistant reads were assigned to HMT-764 at this body site (ANA).
Because HMT-609 is not present individually, all equidistant reads were assigned to HMT-764 at these sites (BMU,PTO,SAL).
Some of the reads equidistant from these taxa (099-682-764) are included in HMT-764 because they are too close to differentiate at these sites (AKE,ANA,RRC,SAL,SUBP).
Reads equidistant to HMT-682 and HMT-764 were assigned to each taxon in proportion to the abundance of HMT-682 and HMT-764 individually at these sites (AKE,HPA,LAF,RAF,SUBP,SUPP,THR).
Because HMT-682 is not present individually, all equidistant reads were assigned to HMT-764 at this body site (ANA).
Because HMT-609 is not present individually, all equidistant reads were assigned to HMT-764 at these sites (BMU,PTO,SAL).
Some of the reads equidistant from these taxa (099-682-764) are included in HMT-764 because they are too close to differentiate at these sites (AKE,ANA,RRC,SAL,SUBP).
Reads equidistant to HMT-682 and HMT-764 were assigned to each taxon in proportion to the abundance of HMT-682 and HMT-764 individually at these sites (AKE,HPA,LAF,RAF,SUBP,SUPP,THR).
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | LAF | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 1.69 | 2.60 | 0.40 | 0.66 | 0.50 | 0.71 | 0.09 | 0.12 | 0.03 | 0.06 | 0.09 | 0.06 | 0.09 | 0.13 | 0 | 0 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 4.55 | 7.81 | 0.85 | 2.31 | 0.93 | 1.99 | 0.19 | 0.16 | 0.07 | 0.20 | 0.05 | 0.04 | 0.15 | 0.20 | 0 | 0 | 0 | 0 |
| Stdev | 4.11 | 5.07 | 1.21 | 1.62 | 1.79 | 1.66 | 0.32 | 0.64 | 0.07 | 0.15 | 0.98 | 0.47 | 0.41 | 0.59 | 0 | 0 | 0 | 0 |
| Prev(%) | 78.15 | 88.74 | 55.94 | 68.49 | 66.44 | 65.39 | 45.83 | 50.67 | 45.81 | 37.00 | 25.00 | 19.55 | 22.99 | 24.89 | 0 | 0 | 0 | 0 |
Human Microbiome Project 16S RefSeq (V3-V5) (Data from healthy subjects. - not published)
Notes:
No data – the v3v5 region of the 16S rRNA gene does not distinguish this species from its close relatives.
No data – the v3v5 region of the 16S rRNA gene does not distinguish this species from its close relatives.
Dewhirst 35x9 (35 Taxa by 9 Oral Sites. - not published)
Notes:
Reads equally close to HMT 099, 609, 682, and 764 were assigned one fourth to each taxon.
Reads equally close to HMT 099, 609, 682, and 764 were assigned one fourth to each taxon.
| SUBP | SUPP | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | |
| Avg (%) | 0.10 | 0.06 | 0.01 | 0.06 | 0.15 | 0.05 | 0.01 | 0.01 | 0 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 90thp | 0.07 | 0.15 | 0.04 | 0.16 | 0.40 | 0.09 | 0.01 | 0.03 | 0.01 | 0 |
| Stdev | 0.39 | 0.17 | 0.02 | 0.11 | 0.40 | 0.17 | 0.01 | 0.04 | 0.01 | 0 |
| Prev(%) | 60.81 | 64.71 | 48.84 | 74.29 | 75.00 | 66.00 | 63.64 | 58.06 | 50.00 | 0 |
Human Microbiome Project Metaphlan (Data from healthy subjects. - not published)
No Notes
| SUBP | SUPP | PERIO | AKE | BMU | HPA | SAL | THR | PTO | TDO | ANA | LRC | RRC | RAF | VIN | MVA | PFO | STO | |
| Avg (%) | 1.59 | 2.57 | 0.52 | 0.17 | 1.22 | 0.68 | 0.59 | 0.02 | 0.15 | 0.04 | 0.01 | 0.03 | 0.04 | 0.12 | 0 | 0.01 | 0.01 | 0 |
| n | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN | NaN |
| 10thp | 0 | 0 | 0 | 0 | 0 | 0.68 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.12 | 0 | 0 | 0 | 0 |
| 90thp | 3.22 | 6.50 | 0.14 | 0.40 | 3.39 | 0.68 | 1.16 | 0.05 | 0.09 | 0.09 | 0 | 0.02 | 0.01 | 0.12 | 0 | 0 | 0 | 0 |
| Stdev | 2.17 | 4.36 | 2.39 | 0.39 | 2.59 | 0 | 0.58 | 0.07 | 0.62 | 0.13 | 0.08 | 0.11 | 0.17 | 0 | 0 | 0.05 | 0.11 | 0.05 |
| Prev(%) | 79.17 | 89.39 | 29.17 | 35.29 | 77.93 | 100.00 | 75.00 | 25.00 | 48.00 | 47.89 | 7.66 | 20.83 | 15.63 | 100.00 | 0 | 7.14 | 2.02 | 0.55 |

